Matrisome Bio
2 known investors
Matrisome Bio develops therapies that deliver drug payloads to the extracellular matrix (ECM) of solid tumors and metastases while sparing normal tissue, using a platform of nanobody-based binders that turn the tumor matrix into a drug depot. It targets metastatic solid tumors in oncology, focusing on ECM components that are broadly present across tumor types.
BiotechDeep TechHealthtech
Founders & leadership
NJ
Noor JailkhaniinFounder
Investors · 2
Frequently asked questions
- What does Matrisome Bio do?
- Matrisome Bio develops therapies that deliver drug payloads to the extracellular matrix (ECM) of solid tumors and metastases while sparing normal tissue, using a platform of nanobody-based binders that turn the tumor matrix into a drug depot. It targets metastatic solid tumors in oncology, focusing on ECM components that are broadly present across tumor types.
- Who founded Matrisome Bio?
- Matrisome Bio was founded by Noor Jailkhani.
- Who are Matrisome Bio's investors?
- Matrisome Bio's investors include Bold Capital Partners, The Engine Ventures.